Citigroup Inc. vs BIO-TECHNE Corp — how do they compare? Citigroup Inc. trades at $133.95 (market cap $239.99B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: Citigroup Inc. is far larger — about 21.6× BIO-TECHNE Corp's market cap, and Citigroup Inc. pays the higher dividend (1.71%). Which is the better fit depends on your goals.
| C | TECH | |
|---|---|---|
Market Cap | $239.99B | $11.12B |
Sector | Financials | Health |
52-Week High | $145.67 | $71.38 |
52-Week Low | $90.02 | $43.31 |
Dividend Yield | 1.71% | 0.45% |
Enterprise Value | — | $11.20B |
Trailing returns across standard periods
Latest headlines on both assets
Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.
Read more on C →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →